Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
F
|
Fujian South Highway Machinery Co Ltd
SSE:603280
|
CN |
|
JW Pharmaceutical Corp
KRX:001060
|
KR |
|
Ingredion Inc
NYSE:INGR
|
US |
|
Nabtesco Corp
TSE:6268
|
JP |
|
D
|
DT Cloud Star Acquisition Corp
NASDAQ:DTSQ
|
US |
|
R
|
Roquefort Therapeutics PLC
LSE:ROQ
|
UK |
|
Maisons du Monde SA
PAR:MDM
|
FR |
|
Antares Vision SpA
MIL:AV
|
IT |
|
N
|
NeoVolta Inc
NASDAQ:NEOV
|
US |
|
Loews Corp
NYSE:L
|
US |
|
Minim Inc
NASDAQ:MINM
|
US |
|
T
|
Trident Texofab Ltd
BSE:540726
|
IN |
|
Notable Labs Ltd
NASDAQ:NTBL
|
IL |
|
R
|
Rathdowney Resources Ltd
OTC:RATHF
|
CA |
|
A
|
Alset Inc
F:42A0
|
US |
|
S
|
Shakey's Pizza Asia Ventures Inc
XPHS:PIZZA
|
PH |
|
NU Skin Enterprises Inc
NYSE:NUS
|
US |
|
D
|
DS Sigma Holdings Bhd
KLSE:DSS
|
MY |
|
KT Corp
NYSE:KT
|
KR |
|
G
|
Golden Energy Offshore Services AS
OSE:GEOS
|
NO |
|
KT Corp
KRX:030200
|
KR |
|
Macmahon Holdings Ltd
ASX:MAH
|
AU |
|
Vital Metals Ltd
ASX:VML
|
AU |
Profitability Summary
Inhibikase Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Inhibikase Therapeutics Inc
Margins Comparison
Inhibikase Therapeutics Inc Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| US |
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
191.6m USD |
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD |
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD |
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD |
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD |
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD |
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD |
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Inhibikase Therapeutics Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
191.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
